Purchase Order N4034524P0010

This is a firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for MiSeq maintenance and service. The contract has a ceiling value of $125,421.00 and a period of performance from August 29, 2022, to August 29, 2025. The contract does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has previously...

This firm fixed-price purchase order contract, valued at $210,400.00, was awarded by the U.S. Navy Bureau of Medicine and Surgery to the University of Malaya, a public research university in Malaysia. The contract supports medical research services related to respiratory illnesses, febrile diseases, and COVID-19. The work includes surveillance studies, etiology research, and immunity studies as part of programs like the Defense Advanced Research Projects Agency (DARPA) ECHO initiative and...

This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract, valued at $80,858.46, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is made under an...

This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...

This federal contract award, valued at $89,232.71, was issued by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc. Illumina, a manufacturer of genomic sequencing instruments and reagents, is providing health check services for BUMED's MiSeq and NextSeq 500 sequencing systems under this firm fixed price purchase order. The award is not associated with a larger contract vehicle and does not have a set-aside designation. Illumina has previously supported genomic research and...

This federal contract award, valued at $141,313.00, was issued by the Department of the Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the provision of a NovaSeq 6000 Silver Support Plan, which includes maintenance and support services for this critical laboratory equipment used by the Naval Medical Research Command (NMRC) for mission-critical sequencing capabilities. The contract...

The Department of the Navy Bureau of Medicine and Surgery awarded a $10,426 purchase order to Illumina, Inc. of Rockville, Maryland. The firm fixed price order is for a comprehensive yearly product care plan for two Illumina MiSeq sequencing units. The product care will be delivered from September 30, 2023 through September 30, 2023 and performed at Illumina's Rockville location. No subcontractors or set aside designations were identified. The Bureau supports Navy and Marine Corps medical...

This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a manufacturer of genomic sequencing instrumentation and reagents. The $153,192.00 contract is for the provision of a MiSeq Silver sequencing system and associated products to support the agency's nucleic acid sequencing needs, specifically to characterize biological threats at the Naval Medical Research Center's Biological Defense Research...

This federal contract award to Illumina, Inc. is a purchase order (PO) for a MiSeq System, a genomic sequencing instrument, valued at $95,931.00. The award was made by the U.S. Navy Bureau of Medicine and Surgery (BUMED) and is not associated with a set-aside program. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing these products and related services to various federal agencies, including the National Institutes of Health (NIH),...

This is a $41,137.76 firm fixed price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract is for the delivery of Illumina RNA Prep kits and reagents to support laboratories at the Naval Health Research Center (NHRC) in San Diego, California. The award was made on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), with deliveries scheduled on four dates between...